Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;19(3):542-547.
doi: 10.4103/1673-5374.380876.

Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina

Affiliations
Review

Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina

María Norte-Muñoz et al. Neural Regen Res. 2024 Mar.

Abstract

Advanced mesenchymal stromal cell-based therapies for neurodegenerative diseases are widely investigated in preclinical models. Mesenchymal stromal cells are well positioned as therapeutics because they address the underlying mechanisms of neurodegeneration, namely trophic factor deprivation and neuroinflammation. Most studies have focused on the beneficial effects of mesenchymal stromal cell transplantation on neuronal survival or functional improvement. However, little attention has been paid to the interaction between mesenchymal stromal cells and the host immune system due to the immunomodulatory properties of mesenchymal stromal cells and the long-held belief of the immunoprivileged status of the central nervous system. Here, we review the crosstalk between mesenchymal stromal cells and the immune system in general and in the context of the central nervous system, focusing on recent work in the retina and the importance of the type of transplantation.

Keywords: adaptive immunity; cell therapy; central nervous system; immune system; innate immunity; mesenchymal stromal cells; neuroregeneration; preclinical studies; retina; transplantation.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Summary of MSC and immune system crosstalk. Graphical scheme that summarizes the interaction of MSCs with innate immune cells (yellow arrows) and adaptive immune cells (green arrows). BAX: Bcl-2 associated to X gen; CD: cluster of differentiation; CXCL: chemokine (C-X-C motif); DCs: dendritic cells; HLA: human leukocyte antigen; IDO: indoleamine-2.3-dioxygenase; IL: interleukin; IRAK-1: interleukin-1 receptor-associated kinase 1; MIF: macrophage inhibitory factor; MIP: macrophage inflammatory protein; MSC: mesenchymal stromal cell; NK: natural killer; TGF-β: transforming growth factor-β; Treg: regulatory T cell; Th: helper T cell; PGE2: prostaglandin E2; ULBP3: UL16 binding protein-3. Partly generated using Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license.

References

    1. Andrzejewska A, Dabrowska S, Lukomska B, Janowski M. Mesenchymal stem cells for neurological disorders. Adv Sci (Weinh) 2021;8:2002944. - PMC - PubMed
    1. Asari S, Itakura S, Ferreri K, Liu CP, Kuroda Y, Kandeel F, Mullen Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol. 2009;37:604–615. - PMC - PubMed
    1. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57:1192–1203. - PMC - PubMed
    1. Baranovskii DS, Klabukov ID, Arguchinskaya NV, Yakimova AO, Kisel AA, Yatsenko EM, Ivanov SA, Shegay PV, Kaprin AD. Adverse events, side effects and complications in mesenchymal stromal cell-based therapies. Stem Cell Investig. 2022;9:7. - PMC - PubMed
    1. Bernardo ME, Fibbe WE. Mesenchymal stromal cells:sensors and switchers of inflammation. Cell Stem Cell. 2013;13:392–402. - PubMed